BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20162459)

  • 41. FDG PET, PET/CT, and breast cancer imaging.
    Rosen EL; Eubank WB; Mankoff DA
    Radiographics; 2007 Oct; 27 Suppl 1():S215-29. PubMed ID: 18180228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
    Koga S; Nakano S; Honma Y; Ogasawara N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
    [No Abstract]   [Full Text] [Related]  

  • 43. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Davey K; Heriot AG; Mackay J; Drummond E; Hogg A; Ngan S; Milner AD; Hicks RJ
    Dis Colon Rectum; 2008 Jul; 51(7):997-1003. PubMed ID: 18461399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of FDG positron emission tomography in the management of patients with breast cancer.
    Weir L; Worsley D; Bernstein V
    Breast J; 2005; 11(3):204-9. PubMed ID: 15871707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
    Rosen EL; Turkington TG; Soo MS; Baker JA; Coleman RE
    Radiology; 2005 Feb; 234(2):527-34. PubMed ID: 15671006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of incidental findings on staging positron emission tomography for oesophagogastric malignancies.
    Adams HL; Jaunoo SS
    Ann R Coll Surg Engl; 2014 Apr; 96(3):207-10. PubMed ID: 24780785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Imaging methods in the current diagnosis of and screening for breast cancer].
    Forrai G; Szabó E; Ormándi K; Ambrózay E; Péntek Z; Milics M; Rajtár M; Sinkovics I
    Magy Onkol; 2010 Sep; 54(3):211-6. PubMed ID: 20870598
    [No Abstract]   [Full Text] [Related]  

  • 48. Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy.
    Shie P
    Abdom Imaging; 2011 Apr; 36(2):165-9. PubMed ID: 20458476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraductal papilloma of the breast: F-18 FDG PET demonstration.
    Nguyen BD; Lidner TK
    Clin Nucl Med; 2005 Jul; 30(7):481-2. PubMed ID: 15965323
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of Incidental Breast Lesions Detected at Nuclear Medicine Examinations.
    Rahman WT; Neal CH; Nees AV; Brown RKJ
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190037. PubMed ID: 33778704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PET.
    Nair N; Basu S
    Clin Nucl Med; 2005 Apr; 30(4):289-90. PubMed ID: 15764896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer.
    Sasada S; Masumoto N; Kimura Y; Emi A; Kadoya T; Okada M
    Anticancer Res; 2020 Jun; 40(6):3491-3497. PubMed ID: 32487649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography.
    Ramani SK; Basu S; Parmar V; Gujral S; Bibte S
    J Cancer Res Ther; 2011; 7(3):387-9. PubMed ID: 22044838
    [No Abstract]   [Full Text] [Related]  

  • 54. Intramammary incidental findings on staging computer tomography.
    Surov A; Fiedler E; Wienke A; Holzhausen HJ; Spielmann RP; Behrmann C
    Eur J Radiol; 2012 Sep; 81(9):2174-8. PubMed ID: 21742452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery.
    Cardillo A; De Cicco C; Paganelli G; Ghisini R; Peruzzotti G; Balduzzi A; Goldhirsch A; Rotmensz N; Veronesi P; Luini A; Intra M; Colleoni M
    Ann Oncol; 2007 Feb; 18(2):394-5. PubMed ID: 17043097
    [No Abstract]   [Full Text] [Related]  

  • 56. More is missed by not looking - incidental findings on FDG-PET.
    Lee JC; Chong JW; Hartnett GF
    Clin Imaging; 2024 Jul; 111():110186. PubMed ID: 38781616
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular Imaging and Its Role in the Management of Breast Cancer.
    Kiser J
    Clin Obstet Gynecol; 2016 Jun; 59(2):403-11. PubMed ID: 26982254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography.
    Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
    Sci Rep; 2022 Jan; 12(1):1144. PubMed ID: 35064184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative FDG PET/CT in breast cancer patients: where are we going?
    Gilardi L; De Cicco C; Paganelli G
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1667-9. PubMed ID: 22976500
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidental mammary fibromyoblastoma on 82Rb myocardial perfusion imaging.
    Pelletier-Galarneau M; Martineau P; Davies RA
    Clin Nucl Med; 2015 Apr; 40(4):343-4. PubMed ID: 25546224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.